Showing results (111-120 of 126) with videos related to
Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|July 9, 2024
AB-free kava enhances resilience against the adverse health effects of tobacco smoke in miceTengfei Bian, Allison Lynch, Kayleigh Ballas, et al.Oncogene|December 7, 2018
Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4Ryan Kolb, Paige Kluz, Zhen Wei Tan, et al.Journal for Immunotherapy of Cancer|July 31, 2021
Intratumoral talimogene laherparepvec injection with concurrent preoperative radiation in patients with locally advanced soft-tissue sarcoma of the trunk and extremities: phase IB/II trialVarun Monga, Benjamin J Miller, Munir Tanas, et al.Blood|July 24, 2024
KDM6A regulates immune response genes in multiple myelomaDaphné Dupéré-Richer, Alberto Riva, Benjamin G Barwick, et al.Nature Communications|October 7, 2016
Obesity-associated NLRC4 inflammasome activation drives breast cancer progressionRyan Kolb, Liem Phan, Nicholas Borcherding, et al.Biorxiv : the Preprint Server for Biology|February 26, 2024
KDM6A Regulates Immune Response Genes in Multiple MyelomaDaphne Dupéré-Richer, Alberto Riva, Sayantan Maji, et al.Biorxiv : the Preprint Server for Biology|September 2, 2025
CerS2 is a druggable target in triple-negative breast cancerHissah Alatawi, Haritha H Nair, Lingbao Ai, et al.Oncogene|February 12, 2020
Cancer cell-intrinsic function of CD177 in attenuating β-catenin signalingPaige N Kluz, Ryan Kolb, Qing Xie, et al.Molecular Cancer Therapeutics|April 21, 2026
CerS2 is a druggable target in triple-negative breast cancerHissah Alatawi, Haritha H Nair, Lingbao Ai, et al.Nature Communications|November 26, 2021
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activityDongwen Lv, Pratik Pal, Xingui Liu, et al.Pageof 13